A specific new ELISA method for analyzing cetuximab

(Bentham Science Publishers) Cetuximab (CET) is a monoclonal antibody that inhibits epidermal growth factor receptor (EGFR) used for immunotherapy of different types of cancer. This study describes the development and full validation of a new enzyme-linked immunosorbent assay (ELISA) with high sensitivity and selectivity for bioanalysis of CET.